@article{e998f9e00aa74d74afeb885b9676da91,
title = "Editors' welcome and a working definition for a multiple sclerosis cure",
author = "Brenda Banwell and Gavin Giovannoni and Christopher Hawkes and Fred Lublin",
note = "Funding Information: Gavin Giovannoni received research grant support from Bayer-Schering Healthcare, Biogen-Idec, GW Pharma, Merck Serono, Merz, Novartis, Teva and Sanofi-Aventis. He received personal compensation for participating on Advisory Boards in relation to clinical trial design, trial steering committees and data and safety monitoring committees from: Bayer-Schering Healthcare, Biogen-Idec, Eisai, Elan, Fiveprime, Genzyme, Genentech, GSK, GW Pharma, Ironwood, Merck-Serono, Novartis, Pfizer, Roche, Sanofi-Aventis, Synthon BV, Teva, UCB Pharma and Vertex Pharmaceuticals. In the past 5 years Christopher Hawkes received royalties from the Massachusetts Medical Society and Cambridge University Press, and also he has received an honorarium from Teva Pharmaceuticals and educational support from Sanofi Genzyme.",
year = "2013",
month = apr,
doi = "10.1016/j.msard.2012.12.001",
language = "English",
volume = "2",
pages = "65--67",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier B.V.",
number = "2",
}